Conclusion
Drug concentration monitoring should currently be considered only as a tool to supplement clinical assessment of patient response. Consideration of appropriate drug selection, dosage and clinical monitoring of response is the most crucial component of patient therapy. Confirmation is required of the benefits of drug concentration monitoring in influencing patient outcome. Similarly, further research into methods of measuring drug concentrations at receptor sites, and the correlation of such concentration with outcome, would be a valuable addition to clinical assessment in adjusting drug therapy to achieve desirable patient outcomes. Until such data are available, only selective use of drug concentration monitoring is warranted in the appropriate clinical care of patients and to prevent inappropriate use of healthcare resources.
Similar content being viewed by others
References
Bauman JL, Schoen MD, Hoon TJ. Practical optimisation of antiarrhythmic drug therapy using pharmacokinetic principles. Clinical Pharmacokinetics 20: 151–166, 1991
Bootman JL, Wertheimer AI, Zaske D, Rowland C. Individualizing gentamicin dosage regimens in burn patients with gramnegative septicemia: a cost-benefit analysis. Journal of Pharmaceutical Sciences 68: 267–272, 1979
Echizen H, Eichelbaum M. Clinical pharmacokinetics of verapamil, nifedipine and diltiazem. Clinical Pharmacokinetics 11: 425–449, 1986
McCormack JP, Jewesson PJ. A critical reevaluation of the ‘therapeutic range’ of aminoglycosides. Clinical Infectious Diseases 14: 320–339, 1992
McInnes GT. The value of therapeutic drug monitoring to the practising physician — an hypothesis in need of testing. British Journal of Clinical Pharmacology 27: 281–284, 1989
Oosterhuis B, Van Boxtel CJ. Kinetics of drug effects in man. Therapeutic Drug Monitoring 10: 121–132, 1988
Spector R, Park GD, Johnson GF, Vesell ES. Therapeutic drug monitoring. Clinical Pharmacology and Therapeutics 43: 345–353, 1988
Watson ID, Thomson AH. The value of therapeutic drug monitoring to the practising physician — an hypothesis needing sensible application! British Journal of Clinical Pharmacology 28: 619–620, 1989
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Brown, G.R., Miyata, M. & McCormack, J.P. Drug Concentration Monitoring. Clin. Pharmacokinet. 24, 187–194 (1993). https://doi.org/10.2165/00003088-199324030-00001
Published:
Issue Date:
DOI: https://doi.org/10.2165/00003088-199324030-00001